Researchers discovered the second ‘key’ used by the SARS-CoV-2 virus to enter into huma

To efficiently infect human cells, SARS-CoV-2, the virus that causes COVID-19, is able to use a receptor called Neuropilin-1, which is very abundant in many human tissues including the respiratory tract, blood vessels and neurons. The breakthrough discovery was made by a German-Finnish team of researchers led by neuroscientists Mika Simons ,Technical University of Munich,…

Details

Centivax signs licensing agreement with Thermo Fisher for its anti-COVID-19 antibodies

Centivax Inc, the therapeutics spinout of Contract Research Organization Distributed Bio Inc, announced today a licensing agreement with Thermo Fisher Scientific. Thermo Fisher has developed and evaluated several variants of Centivax’s highly specific and effective therapeutic antibody candidates against COVID-19 for use in research, including flow cytometry, histopathology, in vitro and in vivo neutralization, Luminex…

Details